Atlas Trials

A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis

Clinical trial NCT02465606 · COMPLETED

Trial details

NCT number
NCT02465606
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Atopic Dermatitis
Start date
2015-07-30
Primary completion
2016-05-30
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.